SCHEMBL6428320

SCHEMBL6428320

Cc1c(C(C(=O)O)C(C)(C)C)c2cc(O)c(F)cc2n1C(=O)c1cccc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.36
ALDH1A1 P00352 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
AKR1C3 P42330 3/20 0.35
AKR1C2 P52895 3/20 0.35
PTGS2 P35354 2/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
ELANE P08246 2/20 0.34
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
ITGA5 P08648 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
SLC6A2 P23975 1/20 0.33
CHRNB4 P30926 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428310 0.90 AKR1C3 (0.40) SRCALDH1A1KMT2AAKR1C3AKR1C2
SCHEMBL6423233 0.89 AKR1C3 (0.44) MEN1KMT2AAKR1C3AKR1C2PTGS2
SCHEMBL5558651 0.88 PTGS2 (0.43) SRCALDH1A1L3MBTL1POLBMEN1
SCHEMBL5558646 0.88 PTGS2 (0.43) SRCALDH1A1L3MBTL1POLBMEN1
SCHEMBL6425546 0.88 MEN1 (0.34) SRCMEN1KMT2AAKR1C3AKR1C2
SCHEMBL5547116 0.88 PTGS2 (0.43) SRCALDH1A1L3MBTL1POLBMEN1
SCHEMBL6424837 0.87 AKR1C3 (0.34) SRCAKR1C3AKR1C2PTGS2
SCHEMBL6423888 0.87 RORC (0.35) SRCAKR1C3AKR1C2PTGS2
SCHEMBL6422823 0.87 PTGS2 (0.37) SRCALDH1A1L3MBTL1POLBMEN1
SCHEMBL6424963 0.86 MEN1 (0.36) SRCALDH1A1L3MBTL1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 SRC 3467/4885ALDH1A1 630/4885L3MBTL1 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.